TrialBMC women's health2021

Relugolix for oral treatment of uterine leiomyomas: a dose-finding, randomized, controlled trial.

Hiroshi Hoshiai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.